Michael A. Snyder

Michael A. Snyder
Name	Michael A. Snyder
Birth date	1955
Birth place	New Jersey, United States
Nationality	American
Fields	Genomics, Genetics, Systems Biology, Bioinformatics
Workplaces	Stanford University, Stanford University School of Medicine, Stanford Genome Technology Center
Alma mater	Stanford University, Columbia University
Known for	Functional genomics, personal genomics, chromatin mapping, disease genomics
Awards	Paul K. Pedersen Lecture, E. Mead Johnson Award, membership in National Academy of Medicine

Michael A. Snyder is an American geneticist and genomicist known for pioneering work in functional genomics, chromatin mapping, and personal genomics. He has held faculty positions at Stanford University and leadership roles at the Stanford Genome Technology Center, contributing to projects that span transcriptional regulation, epigenomics, and application of genomics to disease. Snyder’s work bridges laboratory methods, computational analyses, and translational studies linking genomic variation to phenotypes.

Early life and education

Snyder was born in 1955 in New Jersey and grew up in an environment that encouraged science and engineering, later attending Stanford University for undergraduate studies. He pursued graduate training at Columbia University in the laboratory of prominent molecular biologists, where he studied gene regulation and developed early expertise in molecular cloning, nucleic acid technologies, and hybridization methods. Postdoctoral training included work at research centers associated with Stanford University School of Medicine and collaborations with faculty at institutions such as Massachusetts Institute of Technology and Harvard University, during which he became conversant with emerging technologies like high-throughput sequencing and microarrays.

Academic and research career

Snyder joined the faculty of Stanford University where he established a laboratory that integrated experimental genomics with computational biology. He served as director of the Stanford Genome Technology Center and held appointments in departments linked to molecular biology and genetics, working alongside colleagues from Palo Alto Veterans Hospital, Lucile Packard Children's Hospital Stanford, and collaborative centers connected to NIH initiatives. Throughout his career he has mentored graduate students and postdoctoral fellows who later joined faculties at institutions including University of California, San Francisco, Massachusetts Institute of Technology, Broad Institute, University of Washington, and Johns Hopkins University.

Snyder’s laboratory helped develop and scale technologies such as chromatin immunoprecipitation followed by sequencing (ChIP-seq) and nascent RNA profiling, collaborating with groups at Illumina, the ENCODE Project Consortium, and the International Human Genome Sequencing Consortium. He participated in consortia including the ENCODE Project, the Roadmap Epigenomics Project, and large-scale efforts that intersect with programs by the National Human Genome Research Institute and the National Institutes of Health.

Major contributions and research focus

Snyder is credited with foundational studies in functional genomics that mapped transcription factor binding, chromatin states, and regulatory landscapes across human and model organism genomes. His team produced genomic atlases that connected regulatory elements to gene expression patterns, intersecting with work from the ENCODE Project and the Roadmap Epigenomics Project. Snyder advanced personal, longitudinal genomics by conducting deep multi-omics profiling of individuals over time, integrating data types used by groups at MIT Broad Institute, Harvard Medical School, and the Scripps Research Translational Institute.

Key contributions include development and refinement of methods for chromatin mapping, proteomics integration with genomics, and single-cell profiling approaches that aligned with techniques from 10x Genomics, Pacific Biosciences, and single-cell consortia at Stanford Medicine. Snyder’s studies linked copy number variation and rare variants to functional consequences, collaborating with disease-focused teams at Mayo Clinic, Cleveland Clinic, and the Children's Hospital of Philadelphia. His laboratory also explored applications of genomics to metabolic and cardiovascular phenotypes, often working with clinical investigators at Stanford Health Care and public health groups such as Centers for Disease Control and Prevention collaborators.

Snyder contributed to translational genomics by integrating genomic data with electronic health records, fostering connections with initiatives at Geisinger Health System, Mount Sinai Health System, and other medical centers pursuing precision medicine. His interdisciplinary approach combined experimental platforms, computation from groups at Carnegie Mellon University and Georgia Institute of Technology, and statistical genetics frameworks used by researchers at University of Michigan and Yale School of Medicine.

Awards and honors

Snyder’s achievements have been recognized by election to major academies and receipt of prestigious prizes. He is an elected member of the National Academy of Medicine and has received awards such as the E. Mead Johnson Award and invitations to deliver named lectures including the Paul K. Pedersen Lecture. He has held leadership roles in professional societies including the American Society of Human Genetics and advisory positions for funding agencies like the National Institutes of Health and philanthropic organizations such as the Gordon and Betty Moore Foundation and the Howard Hughes Medical Institute.

Personal life and legacy

Snyder has balanced laboratory leadership with teaching responsibilities at Stanford University School of Medicine and outreach to public audiences on genomics and personalized medicine topics at venues such as the American Association for the Advancement of Science meetings and popular science forums. His mentees, collaborators, and consortia contributions have shaped fields associated with regulatory genomics, epigenetics, and precision health, influencing programs at institutions including the Broad Institute, Wellcome Trust Sanger Institute, and international partners in Europe and Asia. Snyder’s legacy includes technological platforms, data resources, and a cadre of scientists who continue to advance translational genomics and systems approaches to human disease.

Category:American geneticists Category:Stanford University faculty Category:Members of the National Academy of Medicine